Project Grant HT94252310495
Award Date
7/1/23
Completion Date
6/30/26
Dollars Obligated
$978K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Antonio, TX 78229, USA
Similar Awards
The University of Texas Health Science Center at San Antonio (UTHSCSA) received a $1,872,750 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on June 1, 2025, supports UTHSCSA's research on "SELISISTAT AS AN ANTI-PROSTATE CANCER AGENT FOR TREATMENT OF PROSTATE CANCER" with a performance period ending on May 31, 2028. As a state-controlled academic medical center with expertise in serving...
The University of Texas Health Science Center at San Antonio received a $1,565,298 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) on September 1, 2025. The grant will support research to target the METTL3 protein and overcome drug resistance in metastatic clear cell renal cell carcinoma. The research aims to transform healthcare for military service members, veterans, and the broader public through innovative, advanced...
The University of Texas Health Science Center at San Antonio (UTHSCSA) received a $508,815 Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This 4-year award, running from September 1, 2023 to August 31, 2027, will support research to transform healthcare for service members and the public through innovative and...
This $1,124,825 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support research at the University of Texas Health Science Center at San Antonio (UTHSCSA) to identify novel therapeutic targets for aggressive prostate cancer through induced pluripotent stem cell modeling of BRCA2 mutant prostate tissue. The award, which runs from August 1, 2024 to July 31, 2027, will enable UTHSCSA to conduct innovative scientific...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $493,610 Project Grant from the Department of Defense's Military Medical Research and Development (CFDA 12.420) program to conduct a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The grant, awarded on August 1, 2024, will support this research project over a 3-year period, with a final completion date of July 31, 2027. As...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,560,000.00 to the University of Texas Health Science Center at Houston (UTHealth) to develop drug conjugates of modified LGR4/5/6 ligands for cancer treatment. The funding supports UTHealth's advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award period runs from August 1, 2024...
The University of Texas Health Science Center of San Antonio was awarded a $620,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from May 2022 through April 2026 to target the lysosomal acid lipase A enzyme to induce cellular stress in ovarian cancer. As part of the Military Medical Research and Development program's goals to transform military and public...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $131,685 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "TARGETED AUDITORY PLASTICITY TRAINING TO IMPROVE CENTRAL HEARING IN MILD TBI", will support research to develop innovative approaches for improving central hearing in individuals with mild traumatic brain injury. The grant has a performance...
This federal Project Grant award of $433,126 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Texas Health Science Center at San Antonio (UTHSCSA) to explore the role of PACAP38 in post-traumatic headache. The research aims to investigate innovative medical solutions for the battlefield and transform healthcare for service members and the broader public. UTHSCSA is a prominent Hispanic-serving academic...
This $1,189,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to target stem-like CD8 T cells in immunotherapy against kidney cancer. The grant was awarded on September 1, 2023 to The University of Texas Southwestern Medical Center, an academic medical institution and component of the University of Texas System, to be completed by August 31, 2027. Through this funding, UT Southwestern will conduct research...